Latest: Take your DNA and RNA extraction to the next level with this new eBook
Latest: First step to In Vitro Diagnostic Regulation (IVDR) certification for ZeptoMetrix
Latest: ValitaCell joins Beckman Coulter Life Sciences
Latest: Optimized microplate for cannabis sample processing
Latest: New line of electrochemistry bench meters simplifies pH, conductivity, and dissolved...
Latest: Food Analysis Summit 2022: AI and nanotechnology in food analysis, food safety and...
Latest: 7 upcoming webinars to empower your research
Take your DNA and RNA extraction to the next level with this new eBook
Cell therapy: A GMP-compatible solution for ensuring clonality during iPSC manufacturing
Fluxion launches a fully packaged ion channel screening solution
First step to In Vitro Diagnostic Regulation (IVDR) certification for ZeptoMetrix
8 upcoming webinars to boost your research
Weighing masterclass: A comprehensive run through of the basics of weighing
Managing the risk of nitrosamines in medicinal drugs
Your essential guide to preparative LC
Streamline PCR and qPCR workflows with automated liquid handling
Meet your sustainability targets with Eppendorf Tubes BioBased
Detection and surveillance of SARS-CoV-2 and emerging pathogens in the environment
Concentration and purification of viruses by using ultrafiltration, incl. Coronavirus – a short...
Cell Imaging Technology
Clinical Laboratory Automation
Flow Cytometers for Screening
Virtual Cancer and Immunology Summit
Food Analysis Summit 2022:...
04 Oct 22 - 04 Oct 22
22 Nov 22 - 22 Nov 22
NEW: Environmental Analysis:...
06 Dec 22 - 12 Dec 22
In this guest editorial, Joe Fredette, senior business development manager with the Biopharmaceuticals team at Waters, reflects on the recent TIDES meeting - the industry’s largest event for oligonucleotide and peptide therapeutics.